EHP Funds Inc’s Quest Diagnostics DGX Stock Holding History

EHP Funds Inc’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,200	Closed	-$419K	–	47
2025 Q3	$419K	Hold	2,200	–	–	0.37%	46
2025 Q2	$395K	Sell	2,200 -1,600	-42%	-$278K	0.14%	30
2025 Q1	$643K	Buy	3,800 +2,400	+171%	+$394K	0.51%	26
2024 Q4	$211K	Hold	1,400	–	–	0.2%	45
2024 Q3	$217K	Buy	+1,400	New	+$209K	0.14%	31
2023 Q4	–	Sell	-2,600	Closed	-$317K	–	209
2023 Q3	$317K	Sell	2,600 -6,350	-71%	-$846K	0.15%	112
2023 Q2	$1.26M	Sell	8,950 -2,040	-19%	-$281K	0.31%	83
2023 Q1	$1.55M	Sell	10,990 -20	-0.2%	-$2.86K	0.3%	94
2022 Q4	$1.72M	Sell	11,010 -16,000	-59%	-$2.3M	0.32%	93
2022 Q3	$3.31M	Sell	27,010 -6,750	-20%	-$889K	0.67%	69
2022 Q2	$4.49M	Sell	33,760 -4,330	-11%	-$590K	0.75%	35
2022 Q1	$5.21M	Buy	+38,090	New	+$5.31M	0.87%	40

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EHP Funds Inc's DGX Position: Q4 2025 in Review

EHP Funds Inc sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 2,200 shares — an estimated $419K sold.

EHP Funds Inc first reported a position in DGX in Q1 2022 and held it in 12 quarters. The position peaked at $5.21M in Q1 2022. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

EHP Funds Inc reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
EHP Funds Inc sold 2,200 Quest Diagnostics shares in Q4 2025, an estimated $419K.
EHP Funds Inc first reported a position in Quest Diagnostics in Q1 2022 and held it in 12 quarters.
EHP Funds Inc's Quest Diagnostics position peaked at $5.21M in Q1 2022.
1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on EHP Funds Inc's 13F filing for Q4 2025, filed 12 Feb 2026.